ContextVision posts Q2 results August 21, 2014 -- Image enhancement developer ContextVision has reported financial results for its 2014 second-quarter and six-month periods.
Fuji to show Synapse 3D upgrade at EHI Live 2014 August 20, 2014 -- Fujifilm Medical Systems said it will be highlighting version 3.3 of its Synapse 3D software at the EHI Live 2014 conference, to be held from 4 to 5 November in Birmingham, U.K.
MeVis' sales remain stable August 12, 2014 -- German medical imaging software developer MeVis Medical Solutions reported flat revenue growth and a slight increase in earnings in its second quarter of 2014.
Lung CAD scheme aces preliminary test August 11, 2014 -- A newly revamped lung computer-aided detection (CAD) algorithm has shown outstanding accuracy in a study of lung lesions from a database and generated few false positives, according to a study published online on 24 July by European Radiology.
Standard mammography image processing best for calcifications August 5, 2014 -- Standard image processing algorithms help mammography detect calcification clusters more effectively than low-contrast or film-screen algorithms and could reduce false positives, according to a U.K. study published in the August issue of the American Journal of Roentgenology.
Marsden group uses 3D printer to create molecular phantom July 25, 2014 -- Researchers from one of Europe's top cancer research facilities think they have achieved a technological milestone by successfully developing a patient-specific molecular imaging phantom using a 3D printer, according to a study published in the August issue of Medical Physics.
ESTI: New 3D tool displays promise for rib evaluations July 14, 2014 -- An automated curved planar reformatting software tool that presents the ribs in an "unfolded" view is starting to prove its clinical value, according to a presentation at the European Society of Thoracic Imaging (ESTI) annual meeting, held last month in Amsterdam.
Rotterdam group helps gauge coronary disease severity July 14, 2014 -- At the same time that a validated fractional flow reserve CT angiography application seems to be nearing U.S. Food and Drug administration approval, a new contender for gauging the severity of coronary disease at CT is pushing its way into the ring. Furthermore, it promises to be a simpler solution, according to a team of Dutch researchers.